Psychedelics
Ketamine and Psilocybin Could Boost the “Integration of New Experiences” By Stimulating Nerves in the Brain
Research from Alex Kwan’s lab has suggested that dendritic plasticity may help support the idea that ketamine and psilocybin can help individuals adopt new perspectives and better process new experiences.
MDMA and Psilocybin Use Linked to Lower Odds of Suicidal Thoughts, Survey Finds
Lifetime use of MDMA is linked to fewer suicidal thoughts, according to the US survey study.
Ketamine Therapy Helps Promote Alcohol Abstinence, Trial Finds
The alcohol-use disorder trial, run by Awakn Life Sciences, has reported its first findings, and it seems like ketamine is a promising treatment.
Canadian Patients Now Have Better Access to Psychedelic-assisted Therapy, Following a Federal Amendment
Doctors in Canada can now request psychedelic-assisted therapies for their patients through a new program, following an amendment to Health Canada’s Special Access Program (SAP).
What Is the Best Approach to Psychedelic Therapy? An Interview With Field Trip’s Ronan Levy
Technology Networks spoke to the co-founder of Field Trip Health, a Toronto-based provider of ketamine therapy, on why 2021 was such a significant year for psychedelics.
Awakn’s Ketamine-gambling Disorder Study Expands to Test Whether the Drug Can Also Treat Binge Eating
The company behind the trial has expanded it to include three other behavioral addictions: binge eating disorder, compulsive sexual behavior and internet gaming disorder.
Quality Testing for Psychedelic Drugs
To date, no classical psychedelic agents have been approved for use as a medicine but what does convention tell us about the way these drugs will be scrutinized and assessed for quality?
A History of LSD: Discovery, the Law and Clinical Research
Stephen Wright reviews the status of pre-clinical and clinical research into the use of LSD to treat a range of conditions and provide insights into the future of research involving this drug.
Psilocybin Is Safe to Use in 10mg and 25mg Doses, Study Finds
The researchers came to their conclusion after providing the drug to participants of a controlled trial of psilocybin-mediated therapy.
The Top 10 Cannabis Stories of 2021
The year posed many challenges, but cannabis businesses, research centers, and reform groups still managed to make impressive headway. Analytical Cannabis looks back on the stories and issues that dominated the cannabis industry in 2021.
